» Articles » PMID: 23318258

Deciphering Signatures of Mutational Processes Operative in Human Cancer

Overview
Journal Cell Rep
Publisher Cell Press
Date 2013 Jan 16
PMID 23318258
Citations 674
Authors
Affiliations
Soon will be listed here.
Abstract

The genome of a cancer cell carries somatic mutations that are the cumulative consequences of the DNA damage and repair processes operative during the cellular lineage between the fertilized egg and the cancer cell. Remarkably, these mutational processes are poorly characterized. Global sequencing initiatives are yielding catalogs of somatic mutations from thousands of cancers, thus providing the unique opportunity to decipher the signatures of mutational processes operative in human cancer. However, until now there have been no theoretical models describing the signatures of mutational processes operative in cancer genomes and no systematic computational approaches are available to decipher these mutational signatures. Here, by modeling mutational processes as a blind source separation problem, we introduce a computational framework that effectively addresses these questions. Our approach provides a basis for characterizing mutational signatures from cancer-derived somatic mutational catalogs, paving the way to insights into the pathogenetic mechanism underlying all cancers.

Citing Articles

UVA-light-induced mutagenesis in the exome of human nucleotide excision repair-deficient cells.

Quintero-Ruiz N, Corradi C, Moreno N, de Souza T, Menck C Photochem Photobiol Sci. 2025; .

PMID: 40063310 DOI: 10.1007/s43630-025-00697-9.


Origin and cell type specificity of mitochondrial DNA mutations in ALS-FTLD human brain organoids.

Nie Y, Szebenyi K, Wenger L, Lakatos A, Chinnery P Sci Adv. 2025; 11(10):eadr0690.

PMID: 40053600 PMC: 11887808. DOI: 10.1126/sciadv.adr0690.


Neuronal somatic mutations are increased in multiple sclerosis lesions.

Motyer A, Jackson S, Yang B, Harliwong I, Tian W, Shiu W Nat Neurosci. 2025; .

PMID: 40038527 DOI: 10.1038/s41593-025-01895-5.


Geographic and age-related variations in mutational processes in colorectal cancer.

Diaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele C medRxiv. 2025; .

PMID: 40034755 PMC: 11875255. DOI: 10.1101/2025.02.13.25322219.


Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model.

Starostecka M, Jeong H, Hasenfeld P, Benito-Garagorri E, Christiansen T, Stober Brasseur C Proc Natl Acad Sci U S A. 2025; 122(9):e2415475122.

PMID: 39993200 PMC: 11892646. DOI: 10.1073/pnas.2415475122.


References
1.
Stephens P, Tarpey P, Davies H, Van Loo P, Greenman C, Wedge D . The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012; 486(7403):400-4. PMC: 3428862. DOI: 10.1038/nature11017. View

2.
Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G . Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446(7132):153-8. PMC: 2712719. DOI: 10.1038/nature05610. View

3.
Hainaut P, Pfeifer G . Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis. 2001; 22(3):367-74. DOI: 10.1093/carcin/22.3.367. View

4.
Pleasance E, Stephens P, OMeara S, McBride D, Meynert A, Jones D . A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2009; 463(7278):184-90. PMC: 2880489. DOI: 10.1038/nature08629. View

5.
Stratton M, Campbell P, Futreal P . The cancer genome. Nature. 2009; 458(7239):719-24. PMC: 2821689. DOI: 10.1038/nature07943. View